Oral amoxicillin-clavulanate: an alternative treatment to refractory Nocardia keratitis—a case report
ASM Case Reports · 07.07.2026 · 2 (4)
DOI: 10.1128/asmcr.00223-25 ↗Kurz gefasst
Fallbericht in der Zeitschrift ASM Case Reports, erschienen am 07.07.2026. Verfasst von Prathishtha Pitchyaiah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research to Prevent Blindness.
Abstract (Originalsprache)
Background
Bacterial keratitis (bacterial corneal infection) is a serious, vision-threatening disease caused by a wide range of bacterial species. The gram-positive bacterium Nocardia spp. is increasingly recognized in keratitis, yet is particularly challenging to treat due to delayed diagnosis and limited efficacy of current ophthalmic therapeutics. Antimicrobial resistance among clinical Nocardia isolates is also rising, further complicating patient outcomes. Herein, we report a case of Nocardia amikacinitolerans keratitis, resistant to amikacin, ciprofloxacin, moxifloxacin, clarithromycin, and ceftriaxone, resulting in a complicated therapeutic course. Case Summary A 53-year-old female presented with bacterial keratitis of the right eye, which over the course of 32 months progressed to scleritis (infection of the sclera) and a progressive, significant decrease in visual acuity to hand motion despite exhaustive topical and systemic antimicrobial therapies. While there is a general lack of efficacy of systemic therapies for bacterial keratitis, oral amoxicillin-clavulanate ultimately proved successful in resolving the infection.
Conclusion
As Nocardia spp. ocular infections become more prevalent, this report underscores the highly virulent nature of this pathogen and provides insights into potential therapeutic modalities in the setting of multidrug resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
ORCID-Profile: Rachel A F Wozniak
Förderung
- Research to Prevent Blindness
Zitieren
APA
Pitchyaiah, P., & Wozniak, R. A. F. (2026). Oral amoxicillin-clavulanate: an alternative treatment to refractory Nocardia keratitis—a case report. ASM Case Reports, 2(4). https://doi.org/10.1128/asmcr.00223-25
Vancouver
Pitchyaiah P, Wozniak RAF. Oral amoxicillin-clavulanate: an alternative treatment to refractory Nocardia keratitis—a case report. ASM Case Reports. 2026;2(4). doi:10.1128/asmcr.00223-25
BibTeX
@article{Pitchyaiah2026,
author = {Pitchyaiah, Prathishtha and Wozniak, Rachel A F},
title = {Oral amoxicillin-clavulanate: an alternative treatment to refractory Nocardia keratitis—a case report},
journal = {ASM Case Reports},
year = {2026},
volume = {2},
number = {4},
doi = {10.1128/asmcr.00223-25}
}
EUVIMED